Pre-admission statin use linked to better 30-day outcomes in brain bleed patients

A brain bleed from a ruptured aneurysm is a terrifying event that leaves patients and families facing a long road to recovery. A new look at data from four major hospitals in China offers a potential clue about how to help patients survive the first month. Researchers found that people who took statins before their admission had a much higher chance of a favorable outcome at 30 days. This favorable outcome means the patient recovered well enough to perform daily tasks without major disability. The odds of this good result were 3.67 times higher for those on statins compared to those who were not. This association held true even after carefully matching the two groups to ensure a fair comparison. It is important to remember that this was an observational study, meaning researchers watched what happened naturally without assigning the drug. Because of this design, we cannot say the statins caused the better recovery. Other factors like baseline cholesterol levels and alcohol use also played a role in the results. The study did not report any safety concerns or side effects for the patients taking the medication during this short window. However, the good news did not last. When the team looked at recovery at 90 days, the benefit of statins disappeared. The initial boost in recovery did not extend to the longer term. Experts say we need more rigorous trials to confirm these findings before changing how doctors treat patients.